Kiniksa Pharmaceuticals International, plc

KNSA ·Healthcare, Drug Manufacturers - General
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $459.7M

Liabilities Breakdown FY2022

Total Liabilities: $63.5M